Variant report

Variant	rs882829
Chromosome Location	chr15:40607689-40607690
allele	C/G
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:1)
CpG islands
(count:0)
Chromatin interactive
region (count:6)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:1 , 50 per page) page: 1

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	GATA2	chr15:40605734-40607720	HUVEC	blood vessel:	n/a	n/a

No data

(count:6 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr15:40607352..40610567-chr15:40611377..40615529,4	MCF-7	breast:
2	chr15:40606578..40610704-chr15:40612489..40616999,9	K562	blood:
3	chr15:40597155..40599934-chr15:40605080..40607975,2	K562	blood:
4	chr15:40606578..40609257-chr15:40612890..40617072,4	K562	blood:
5	chr15:40601542..40603378-chr15:40607620..40610047,2	MCF-7	breast:
6	chr15:40596629..40600129-chr15:40604012..40607975,4	K562	blood:

No data

Variant related genes	Relation type
ENSG00000244705	TF binding region
ENSG00000137841	Chromatin interaction

Extended variants
information (count: 21 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:16)

rs_ID	r²[population]
rs1077476	1.00[CEU][hapmap];0.81[CHB][hapmap];0.90[JPT][hapmap];0.90[AMR][1000 genomes];0.88[EUR][1000 genomes]
rs11070264	1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];0.97[AMR][1000 genomes];0.91[EUR][1000 genomes];0.99[ASN][1000 genomes]
rs12081	1.00[CEU][hapmap];0.95[CHB][hapmap];0.91[JPT][hapmap];0.94[AMR][1000 genomes];0.88[EUR][1000 genomes]
rs2118961	1.00[CHB][hapmap];1.00[JPT][hapmap];0.91[AMR][1000 genomes];0.99[ASN][1000 genomes]
rs2289333	1.00[CEU][hapmap];0.95[CHB][hapmap];0.90[JPT][hapmap];1.00[AFR][1000 genomes];0.97[AMR][1000 genomes];0.98[EUR][1000 genomes]
rs2289334	0.94[AMR][1000 genomes];0.88[EUR][1000 genomes]
rs4277318	0.95[ASN][1000 genomes]
rs4334271	0.86[JPT][hapmap]
rs4923863	0.97[AMR][1000 genomes];0.89[EUR][1000 genomes];0.96[ASN][1000 genomes]
rs4923864	0.86[AMR][1000 genomes];0.95[EUR][1000 genomes]
rs4924455	0.81[CHB][hapmap];0.86[JPT][hapmap];0.94[AMR][1000 genomes];0.95[EUR][1000 genomes]
rs7164564	0.90[AMR][1000 genomes];0.86[EUR][1000 genomes]
rs7164747	0.97[AMR][1000 genomes];0.97[EUR][1000 genomes]
rs7173747	1.00[CEU][hapmap];0.95[CHB][hapmap];0.90[JPT][hapmap];0.82[AMR][1000 genomes];0.86[EUR][1000 genomes]
rs748245	0.82[CHB][hapmap]
rs934937	0.86[CHB][hapmap];0.82[JPT][hapmap]

Variant overlapped rSNPs/rCNVs (count:5 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	esv34145	chr15:40549617-40889824	Weak transcription Strong transcription Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS Bivalent Enhancer Genic enhancers ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	66 gene(s)	inside rSNPs	diseases
2	nsv510660	chr15:40552906-40721883	Strong transcription Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS ZNF genes & repeats Genic enhancers Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	34 gene(s)	inside rSNPs	diseases
3	esv1850798	chr15:40560607-40622191	Enhancers Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Strong transcription Bivalent Enhancer Bivalent/Poised TSS Genic enhancers ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	27 gene(s)	inside rSNPs	diseases
4	nsv827305	chr15:40596162-40625922	Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer ZNF genes & repeats Weak transcription Bivalent/Poised TSS Active TSS Strong transcription Genic enhancers Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	22 gene(s)	inside rSNPs	diseases
5	nsv984054	chr15:40603452-40612578	Weak transcription Bivalent Enhancer Flanking Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region lncRNA	9 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:42 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr15:40584200-40614800	Weak transcription	Gastric	stomach
2	chr15:40600000-40614600	Weak transcription	Brain Substantia Nigra	brain
3	chr15:40601200-40612800	Weak transcription	Right Ventricle	heart
4	chr15:40602000-40612600	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
5	chr15:40602000-40613000	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
6	chr15:40602000-40614600	Weak transcription	Rectal Mucosa Donor 29	rectum
7	chr15:40602200-40612600	Weak transcription	Spleen	Spleen
8	chr15:40602600-40614600	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
9	chr15:40604600-40607800	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
10	chr15:40604600-40608000	Enhancers	Primary T cells fromperipheralblood	blood
11	chr15:40605000-40607800	Enhancers	Primary T killer naive cells fromperipheralblood	blood
12	chr15:40605200-40607800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
13	chr15:40605400-40608000	Enhancers	Primary hematopoietic stem cells	blood
14	chr15:40605600-40607800	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
15	chr15:40605600-40607800	Enhancers	HMEC	breast
16	chr15:40605600-40608000	Enhancers	HSMM	muscle
17	chr15:40605600-40608200	Enhancers	Osteobl	bone
18	chr15:40605800-40607800	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
19	chr15:40605800-40607800	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
20	chr15:40605800-40607800	Enhancers	NHDF-Ad	bronchial
21	chr15:40605800-40608000	Enhancers	Muscle Satellite Cultured Cells	--
22	chr15:40605800-40608200	Enhancers	HUVEC	blood vessel
23	chr15:40606000-40615200	Weak transcription	Psoas Muscle	Psoas
24	chr15:40606200-40607800	Enhancers	NHEK	skin
25	chr15:40606400-40607800	Enhancers	HSMMtube	muscle
26	chr15:40606400-40608000	Enhancers	Primary hematopoietic stem cells short term culture	blood
27	chr15:40606600-40607800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
28	chr15:40606600-40615000	Weak transcription	Colonic Mucosa	Colon
29	chr15:40606800-40608000	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
30	chr15:40607200-40607800	Bivalent Enhancer	IMR90 fetal lung fibroblasts Cell Line	lung
31	chr15:40607200-40607800	Enhancers	Lung	lung
32	chr15:40607200-40607800	Enhancers	NHLF	lung
33	chr15:40607200-40608200	Weak transcription	Primary T helper cells PMA-I stimulated	--
34	chr15:40607200-40613000	Weak transcription	Primary T helper cells fromperipheralblood	blood
35	chr15:40607400-40608400	Weak transcription	Fetal Brain Female	brain
36	chr15:40607400-40612400	Weak transcription	Fetal Heart	heart
37	chr15:40607400-40612600	Weak transcription	Pancreas	Pancrea
38	chr15:40607400-40613000	Weak transcription	Primary T helper naive cells fromperipheralblood	blood
39	chr15:40607400-40613000	Weak transcription	Fetal Thymus	thymus
40	chr15:40607400-40614600	Weak transcription	Hela-S3	cervix
41	chr15:40607600-40612600	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
42	chr15:40607600-40614600	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links